Why Does Codeine Cause Itching & What You Can Do About It

Codeine triggers itching through two distinct pathways: it directly activates mast cells in the skin, causing them to release histamine and other inflammatory chemicals, and it separately acts on opioid receptors in the spinal cord to amplify itch signaling in the nervous system. This dual mechanism is why codeine-related itch can be stubborn and why antihistamines alone sometimes fail to control it. The good news is that the itch is almost never a sign of a true allergy, and several strategies can reduce or eliminate it.

How Codeine Makes Skin Mast Cells Release Histamine

For decades, researchers knew that codeine caused mast cells to dump their contents, including histamine, but the exact trigger was murky. The picture became much clearer with the identification of a receptor called MRGPRX2 on the surface of human skin mast cells. Codeine binds directly to MRGPRX2 and prompts the cell to degranulate, spilling histamine, chemokines, and cytokines into surrounding tissue within about 30 minutes.¹ This is not an allergic reaction in any immunological sense. In a classic allergy, the immune system first builds antibodies (IgE) against a substance, then reacts explosively on the next exposure. Codeine skips that entire process. It pushes the mast cell’s MRGPRX2 button directly, no prior sensitization needed.²

The histamine released in this way does exactly what histamine always does in the skin: it dilates small blood vessels, produces redness, and activates itch-sensing nerve fibers. Some people develop hives or a localized flush, especially near the injection site if codeine is given intravenously. Research has also shown that codeine-stimulated mast cells release several chemokines over the following hours, including substances that recruit other immune cells to the area.³ That secondary wave of inflammation may be one reason the itch can linger even after the initial histamine burst fades.

The Spinal Itch Switch

If histamine were the whole story, an antihistamine should fix codeine itch every time. It often helps, but not always, and sometimes not at all. The reason is a second, entirely separate mechanism operating inside the spinal cord. In the dorsal horn of the spinal cord, pain-sensing neurons normally suppress itch-sensing neurons. Think of it as pain keeping a lid on itch. Opioids like codeine (and the morphine codeine is converted into) weaken that pain-mediated suppression, essentially lifting the lid. When the itch neurons are “disinhibited,” they fire on their own even without any itchy stimulus hitting the skin.⁴

Animal research has confirmed how central this spinal pathway is. When researchers blocked opioid receptors only in the peripheral body (outside the brain and spinal cord), morphine-induced scratching continued unabated. But when they blocked opioid receptors specifically in the spinal cord, the scratching stopped completely.⁵ This tells us something practical: the itch driven by central opioid receptors does not depend on histamine at all, which is why antihistamines can miss it entirely. The receptor most responsible for this central itch is the mu-opioid receptor, while kappa-opioid receptors actually suppress itch, a distinction that has opened up some treatment possibilities discussed further below.⁴

Why Some People Itch Intensely and Others Barely Notice

Person-to-person variability in codeine itch is enormous, and genetics is a big part of the explanation. Codeine itself is actually a prodrug with relatively weak opioid effects. Your liver converts it into morphine through an enzyme called CYP2D6, and morphine is the metabolite that does most of the heavy lifting for both pain relief and side effects like itch. The gene coding for CYP2D6 is one of the most variable genes in the human genome, and the version you carry determines how much morphine you produce from a given dose of codeine.⁶

People who carry extra copies of the CYP2D6 gene, called ultrarapid metabolizers, convert codeine to morphine unusually fast and in unusually large amounts. Studies have found that ultrarapid metabolizers produce roughly 50% higher blood levels of morphine and its breakdown products compared with normal metabolizers given the same codeine dose.⁷ More morphine means more activation of both the skin mast-cell pathway and the spinal itch pathway, so these individuals are disproportionately likely to experience severe itching, along with other opioid side effects like excessive sedation and respiratory depression. In extreme cases, standard codeine doses have caused life-threatening opioid toxicity in ultrarapid metabolizers.⁸

At the other end of the spectrum, poor metabolizers produce very little morphine from codeine. They get almost no pain relief from the drug but also tend to experience fewer opioid side effects, including itch. Between these extremes sits the majority of the population, with intermediate or normal metabolism. The practical takeaway is that if you itch badly every time you take codeine, your CYP2D6 status may be part of the reason. Pharmacogenomic testing for CYP2D6 is increasingly available and can inform whether codeine is a good fit for you or whether an alternative painkiller would be safer and more comfortable.

Beyond genetics, research on the MRGPRX2 pathway has found profound subject-to-subject variability in how strongly codeine activates skin mast cells, even among people with similar overall opioid sensitivity.¹ The reasons are not fully mapped out, but they probably involve differences in MRGPRX2 expression levels and downstream signaling. So even two people producing the same amount of morphine might have very different skin reactions.

How Common Is Codeine Itch, and Does Route of Administration Matter?

The incidence of opioid-induced itch varies wildly depending on how the drug enters the body. For oral codeine, which is the form most people encounter in cough syrups and combination painkillers, about 2 to 20% of patients report itching. That range widens to roughly 10 to 50% with intravenous administration, and balloons to 30 to 100% when opioids are delivered directly into the spinal canal (epidural or spinal routes).⁹ The reason for the steep climb with neuraxial delivery is that the drug reaches the spinal opioid receptors at high concentration, directly activating the disinhibition pathway described earlier.

The enormous range within each route of administration reflects the individual differences in CYP2D6 metabolism, mast cell reactivity, and itch perception already discussed. Pregnancy appears to increase susceptibility, likely because estrogen interacts with opioid receptors in ways that amplify the itch signal.⁹ This is relevant because epidural opioids are commonly used during labor, and itching is one of the most frequent complaints among women receiving them.

It Is Almost Certainly Not an Allergy

One of the biggest misconceptions around codeine itch is that it signals an allergy. Many people who itch after taking codeine tell their doctor they are “allergic” to it, and that label can follow them through their medical records for life, sometimes unnecessarily limiting their pain-management options. True IgE-mediated allergic reactions to opioids do exist, but they are rare relative to how heavily these drugs are used. The difficulty is that the symptoms of histamine release via MRGPRX2 (flushing, hives, itching) look virtually identical to a mild allergic reaction from the outside.¹⁰

Skin-prick testing, the standard tool for diagnosing allergies, is unreliable with opioids precisely because the drugs directly release histamine from mast cells. A positive skin test may reflect that direct histamine release rather than a true allergic sensitization, making it hard to distinguish one from the other. Opioid-specific IgE blood tests are not widely available. The upshot is that many patients carry an “opioid allergy” label based on what was actually a predictable pharmacological side effect. If you have been labeled codeine-allergic solely because it made you itch, it is worth discussing with your doctor whether that label is accurate, because it could unnecessarily rule out effective pain medications in the future.

That said, genuinely dangerous reactions to opioids do happen. If codeine causes throat swelling, difficulty breathing, severe drop in blood pressure, or widespread hives covering the body rapidly, that requires emergency evaluation regardless of the underlying mechanism.

What You Can Do to Manage the Itch

Because two separate mechanisms drive codeine itch, the most effective approach depends on which pathway is dominant for you. In practice, it is usually a combination strategy.

Antihistamines: Over-the-counter options like diphenhydramine or cetirizine can blunt the itch driven by mast cell histamine release. They work best for the skin-level mechanism. If your itch comes with visible hives or flushing, antihistamines are a reasonable first step. Drowsiness is a trade-off with first-generation antihistamines like diphenhydramine, particularly when stacked on top of codeine’s own sedating effects.
Opioid receptor antagonists: For itch driven primarily by the spinal pathway, drugs that block opioid receptors are more effective. Low-dose naltrexone or naloxone can counteract the mu-opioid receptor activation responsible for central itch. A study in patients with severe itch found that about 72% experienced more than a 50% decrease in itch intensity with naltrexone-based treatment, and nearly 90% reported at least some improvement.¹¹ The obvious concern is that blocking opioid receptors can also reverse pain relief, so these drugs are typically used at low doses and under medical supervision.
Dose reduction: Because both mechanisms are dose-dependent, simply lowering the codeine dose (if pain control allows) can reduce itch. This is particularly relevant for ultrarapid metabolizers who may be producing more morphine than their dose would suggest.
Switching opioids: Not all opioids activate MRGPRX2 equally. Research has shown that codeine triggers mast cell degranulation in a dose-dependent manner, but meperidine (pethidine) did not activate mast cells under the same conditions.³ While meperidine has its own set of problems and is rarely a first-line choice, the broader point is that rotating to an opioid with less histamine-releasing activity is a standard clinical strategy when codeine itch is intolerable.

Cooling, Menthol, and Topical Relief

For people dealing with mild to moderate codeine itch who want a non-drug option, cold is surprisingly effective. Applying a cool compress or ice pack wrapped in cloth to the itchiest area provides quick, temporary relief. The mechanism involves a specific ion channel on sensory nerves called TRPM8, which is activated by cold temperatures and by menthol. When TRPM8 fires, it essentially competes with and suppresses itch signaling in the same nerve fibers.¹²

Menthol-containing lotions and creams tap into the same pathway without requiring actual cold. They produce that familiar cooling sensation on the skin and can knock down itch for a while. The relief is temporary, not curative, but stacking a menthol-based topical with an antihistamine can be enough to make the itch tolerable while codeine does its job. Avoiding hot showers and wearing loose, breathable clothing also helps, since heat and friction both lower the itch threshold and make histamine-mediated skin reactions worse.

The Kappa Receptor Angle

One of the more interesting findings in opioid itch research is that not all opioid receptors are equal when it comes to itch. Mu-opioid receptors drive the central itch pathway, but kappa-opioid receptors actually suppress itch.⁴ This has led to research into kappa-receptor agonists as anti-itch treatments. A few drugs that activate kappa receptors are available or in development for conditions involving severe chronic itch, and their effectiveness in that context lends support to the disinhibition model of opioid itch.

For patients on codeine, this means that the future of itch management may involve targeted drugs that selectively block mu receptors in the spinal cord (to stop the itch) while leaving pain relief intact, or drugs that selectively activate kappa receptors to counterbalance the itch-promoting effects. Neither approach is routinely available in clinical practice yet for opioid-induced itch specifically, but the science has progressed enough that these are realistic therapeutic goals rather than theoretical ones.

Codeine Itch in Context with Other Opioids

Codeine is far from the only opioid that causes itch, but it and morphine are among the strongest histamine releasers in the opioid family. Morphine, codeine, and dextromethorphan all activate MRGPRX2 at concentrations that trigger mast cell degranulation.² Synthetic opioids like fentanyl and oxycodone tend to cause less direct histamine release, though they still produce central itch through the spinal mu-receptor pathway. This is why switching from codeine to a synthetic opioid often reduces but does not always eliminate itching.

The relationship between histamine release and the clinical severity of side effects is also not straightforward. Blood histamine levels after opioid administration do not always track neatly with how much a patient itches or how severe their flushing is.¹⁰ This disconnect further supports the idea that the central spinal mechanism accounts for a significant share of opioid itch, especially at lower doses where histamine release from mast cells is modest.

When to Talk to Your Doctor

Mild itching after codeine is common, predictable, and usually manageable with the strategies described above. But there are situations where the itch warrants medical attention rather than self-management. If itching is severe enough to disrupt sleep, if it gets worse with each dose rather than better, or if it is accompanied by swelling, wheezing, or a rash that spreads rapidly, you should contact your prescriber. Severe or worsening symptoms could indicate the uncommon true allergic reaction, or they may simply mean you are converting codeine to morphine too efficiently and need a dose adjustment or a different medication.

If you are taking codeine regularly and the itch is a persistent nuisance, asking about your CYP2D6 status through a pharmacogenomic test is worthwhile. Many pharmacies and health systems now offer this testing, and the result can inform not just your codeine experience but your response to dozens of other medications metabolized by the same enzyme. For people identified as ultrarapid metabolizers, the conversation usually shifts to alternative analgesics rather than trying to manage increasingly aggressive side effects from a drug that is producing too much morphine in their system.⁸

1
PubMed Central. MRGPRX2 Is the Codeine Receptor of Human Skin Mast Cells: Desensitization through β-Arrestin and Lack of Correlation with the FcεRI Pathway
2
PubMed. Opioid toxicity: histamine, hypersensitivity, and MRGPRX2
3
PubMed Central. Codeine induces human mast cell chemokine and cytokine production: involvement of G-protein activation
4
PubMed. Opioid-induced pruritus. Mechanisms and treatment regimens
5
Brain. Central opioid receptors mediate morphine-induced itch and chronic itch via disinhibition
6
PubMed Central. Population Pharmacokinetic Quantification of CYP2D6 Activity in Codeine Metabolism in Ambulatory Surgical Patients for Model-Informed Precision Dosing
7
The Pharmacogenomics Journal. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication
8
PubMed. Codeine intoxication associated with ultrarapid CYP2D6 metabolism
9
Journal of PeriAnesthesia Nursing. Opioid-Induced Pruritus: Etiology, Assessment, and Management
10
PubMed Central. Histamine-releasing and allergenic properties of opioid analgesic drugs: resolving the two
11
PubMed Central. Clinical Efficacy and Safety of Naltrexone Combination Therapy in Older Patients with Severe Pruritus
12
PubMed Central. Cooling the Itch via TRPM8